Completion of the Acquisition of Micromeritics Instruments
23 August 2024
Further to the announcement on 16 July 2024, Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces the completion of the acquisition of Micromeritics Instruments, the world leader in analytical instrumentation for the physical characterisation of particles, powders, and porous materials, following receipt of the required regulatory approval.
END
For and on behalf of Spectris plc.
LEI number: 213800Z4CO2CZO3M3T10
Contacts:
Spectris plc
Mathew Wootton
Investor Relations Director
+44 7500 078880
Teneo
Martin Robinson/Giles Kernick
+44 20 7353 4200
About Spectris
Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive.
We are focused on two key divisions - Spectris Scientific and Spectris Dynamics, which are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,600 people located in more than 30 countries, all united behind our purpose to deliver value beyond measure for all our stakeholders. For more information, visit www.spectris.com.
About Micromeritics
Micromeritics Instrument Corporation is the world's leading manufacturer of high-performance systems to measure density, surface area and porosity, powder rheology and catalyst activity. The company is headquartered in Norcross, Georgia, USA with manufacturing sites in the U.S. and Europe, and direct sales operations throughout North America, Europe, and Asia.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.